【摘 要】
：
Urate transporter 1(URAT1)and glucose transporter 9(GLUT9)are important targets for the development of uric acid-lowering drugs.We previously showed that the flexible linkers of URAT1 inhibitors could enhance their potency.In this study we designed and sy
【机 构】
：
Guangdong Provincial Key Laboratory of Drug Screening,School of Pharmaceutical Sciences,Southern Med
论文部分内容阅读
Urate transporter 1(URAT1)and glucose transporter 9(GLUT9)are important targets for the development of uric acid-lowering drugs.We previously showed that the flexible linkers of URAT1 inhibitors could enhance their potency.In this study we designed and synthesized CDER167,a novel RDEA3710 analogue,by introducing a linker(methylene)between the naphthalene and pyridine rings to increase flexibility,and characterized its pharmacological and pharmacokinetics properties in vitro and in vivo.We showed that CDER167 exerted dual-target inhibitory effects on both URAT1 and GLUT9:CDER167 concentration-dependently inhibited the uptake of[14C]-uric acid in URAT1-expressing HEK293 cells with an IC50 value of 2.08±0.31 μM,which was similar to that of RDEA3170(its IC50 value was 1.47±0.23 μM).Using site-directed mutagenesis,we demonstrated that CDER167 might interact with URAT1 at S35 and F365.In GLUT9-expressing HEK293T cells,CDER167 concentration-dependently inhibited GLUT9 with an IC50 value of 91.55±15.28 μM,whereas RDEA3170 at 100 μM had no effect on GLUT9.In potassium oxonate-induced hyperuricemic mice,oral administration of CDER167(10 mg·kg-1·d-1)for 7 days was more effective in lowering uric acid in blood and significantly promoted uric acid excretion in urine as compared with RDEA3170(20 mg·kg-1·d-1)administered.The animal experiment proved the safety of CDER167.In addition,CDER167 displayed better bioavailability than RDEA3170,better metabolic stability and no hERG toxicity at 100 μM.These results suggest that CDER167 deserves further investigation as a candidate antihyperuricemic drug targeting URAT1 and GLUT9.
其他文献
目的:探讨注射用头孢硫脒质量差异的来源及其与临床不良反应(adverse reaction,ADR)发生的关联性.方法:基于国家评价性抽验和不良反应数据,利用多变量数据分析方法(单因素方差分析、多重比较、相关性分析、线性拟合等),从常规质控项目(质量属性)和晶型(工艺属性)2个角度探讨该药物粉针产品间质量差异及其对临床安全性的影响.结果:注射用头孢硫脒所有质控项目中,仅杂质B和ADR严重报告数呈显著相关,且其差异主要来源于原料贮存和运输或制剂无菌分装过程.晶型与杂质B间拟合相关性最高(相关系数r=0.72
Ischemia/reperfusion(I/R)injury is a major cause of acute kidney injury(AKI)in clinic.The activation of NLRP3 inflammasome is associated with inflammation and renal injury in l/R-induced AKI.In the current study we explored the molecular and cellular mech
We are pleased to present a Special Column on“Drug-and Chemical-induced Liver Injury”.The scope of articles in this issue is diverse,covering a wide range of unanswered questions in this research area faced by both clinicians and basic researchers.Liver i
目的:建立盐酸氨溴索口服液中抑菌剂及矫味剂含量测定方法并考察全国范围内该品种抑菌剂和矫味剂添加情况.方法:采用资生堂MGII C18(250 mm×4.6 mm,5μm)色谱柱,以0.02 mol·L-1乙酸铵溶液(用冰醋酸调节pH至4.5)-甲醇为流动相,梯度洗脱,流速1.0 mL·min-1,柱温为30℃,DAD检测器,检测波长为254 nm和230 nm.结果:盐酸氨溴索与4种抑菌剂、3种矫味剂色谱峰均能良好分离,并质量浓度分别在0.005～0.15 mg· mL-1范围内,苯甲酸钠(r=1.000
High mobility group box 1(HMGB1)is a ubiquitous nuclear protein that is present in almost all cells and regulates the activity of innate immune responses in both intracellular and extracellular settings.Current evidence suggests that HMGB1 plays a pivotal
Previous reports suggested that cinnamaldehyde(CA),the bioactive ingredient in Cinnamomum cassia,can suppress tumor growth,migratory,and invasive abilities.However,the role and molecular mechanisms of CA in GC are not completely understood.In the present
Hepatocellular carcinoma(HCC),the most prevalent liver cancer,is considered one of the most lethal malignancies with a dismal outcome mainly due to frequent intrahepatic and distant metastasis.In the present study,we demonstrated that oroxylin A,a natural
The tumor suppressor p53 is usually inactivated by somatic mutations in malignant neoplasms,and its reactivation represents an attractive therapeutic strategy for cancers.Here,we reported that a new quinolone compound RYL-687 significantly inhibited non-s
White matter injury is the major pathological alteration of subcortical ischemic vascular dementia(SIVD)caused by chronic cerebral hypoperfusion.It is characterized by progressive demyelination,apoptosis of oligodendrocytes and microglial activation,which
As a member of the potassium calcium-activated channel subfamily,increasing evidence suggests that KCNN4 was associated with malignancies.However,the roles and regulatory mechanisms of KCNN4 in PDAC have been little explored.In this work,we demonstrated t